CRISPR Research

We are very happy to announce that CRISPR expert at Harvard/MIT, Professor David Liu will be working with the research team at CHOP. Professor Liu’s work is highly prominent in the field having pioneered the use of engineered CRISPR Cas variants with improved specificity and targeting ability. The advantage of this approach is that bringing a truly cutting-edge technology to treat H-ABC.

Previous
Previous

Rare Disease Day 2020: Raise Awareness & Improve Access to Treatment for Individuals with Rare Diseases

Next
Next

Yet another hugely successful event for our cause